Table 1.
Laboratory data on admission.
| Blood cell count |
Blood chemistry |
Immunology |
Urinalysis |
||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| WBC | 5400 | /μL | TP | 6.8 | g/dL | CH50 | 54 | U/mL | Gravity | 1.01 | |
| RBC | 373 | ×104/μL | Alb | 3.9 | g/dL | C3 | 76.1 | mg/dL | pH | 7.0 | |
| Hb | 11.5 | g/dL | AST | 21 | IU/L | C4 | 19.3 | mg/dL | RBC | 1–4 | /HPF |
| Ht | 35.1 | % | ALT | 11 | IU/L | IgG | 1340.3 | mg/dL | WBC | <1 | /HPF |
| MCV | 94.1 | fl | LDH | 186 | IU/L | IgA | 225.7 | mg/dL | Protein | 2.04 | g/gCr |
| MCHC | 32.8 | % | ALP | 149 | IU/L | IgM | 180.1 | mg/dL | Glucose | (−) | |
| Plt | 25.7 | ×104/μL | Tbil | 0.56 | mg/dL | ANA | (−) | NAG | 8.6 | U/L | |
| BUN | 21.8 | mg/dL | M protein | (−) | |||||||
| Coagulation | Cr | 1.26 | mg/dL | HBs Ag | (−) | ||||||
| APTT | 34.0 | sec | eGFR | 40.8 | mL/min/1.73 m2 | HCV Ab | (−) | ||||
| PT | 99.0 | % | K | 5.0 | mEq/L | ||||||
| INR | 0.97 | INR | P | 3.1 | mg/dL | ||||||
| Fib | 373.0 | mg/dL | UA | 5.4 | mg/dL | ||||||
| Tcho | 255 | mg/dL | |||||||||
| CRP | 0.01 | mg/dL | |||||||||
| FBS | 85 | mg/dL | |||||||||
| HbA1c | 5.3 | % | |||||||||
Aberrant values are underlined.
WBC, white blood cells; RBC, red blood cells; Hb, haemoglobin; Hct, haematocrit; MCV, mean corpuscular volume; MCHC, mean corpuscular haemoglobin concentration; Plt, platelet; APTT, activated partial thromboplastin time; PT, prothrombin time; INR, international normalized ratio; Fib, fibrinogen; TP, total protein; Alb, albumin; AST, aspartate aminotransferase; ALT, alanine aminotransferase; LDH, lactate dehydrogenase; ALP, alkaline phosphatase; Tbil, total bilirubin; BUN, blood urea nitrogen; Cr, creatinine; eGFR, estimated glomerular filtration rate (by the Japanese equation); K, potassium; P, phosphate; UA, uric acid; Tcho, total cholesterol; CRP, C-reactive protein; FBS, fasting blood sugar; HbA1c, haemoglobin A1c (NGSP); CH50, 50% haemolytic complement activity; C3, complement 3; IgG, immunoglobulin G; ANA, antinuclear antibody; M protein, monoclonal protein; HBs Ag, hepatitis B surface antigen; HCV Ab, hepatitis C virus antibody; NAG, N-acetyl glucosaminidase; HPF, high power field.